These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4402874)

  • 1. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
    Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
    Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of -adrenoceptor antagonists on the decline of the chronotropic response to isoprenaline.
    Fenyvesi T; George CF; Dollery CT
    J Pharm Pharmacol; 1972 Apr; 24(4):313-7. PubMed ID: 4402839
    [No Abstract]   [Full Text] [Related]  

  • 5. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
    Baird JR; Linnell J
    J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 7. The haemodynamic effects of ( )-propranolol, dexpropranolol, oxprenolol, practolol and sotalol in anaesthetised dogs.
    Fitzgerald JD; Wale JL; Austin M
    Eur J Pharmacol; 1972 Jan; 17(1):123-34. PubMed ID: 4401429
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
    Alexandre JM; Menard J; Chevillard C; Schmitt H
    Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of beta blockade with serum practolol levels after oral administration.
    Schneck DW; Aoki VS; Kroetz FW; Wilson WR
    Clin Pharmacol Ther; 1972; 13(5):685-93. PubMed ID: 4403358
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
    Okuda K; Chiba S; Taira N; Hashimoto K
    Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Imamura H; Nakamura T; Kimura T
    Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac toxicity of -lytic drugs.
    Roba J
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
    Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
    Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of intravenous pindolol and propranolol in normal man.
    Hicks DC; Arbab AG; Turner P; Hills M
    J Clin Pharmacol New Drugs; 1972; 12(5):212-6. PubMed ID: 4402370
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
    Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.